The New York Times faces a federal lawsuit alleging reverse discrimination in hiring, raising debate over diversity policies in the workplace.
Articles by Madelaine Panganiban
Latest News
Zapp's and Dirty potato chips are recalled nationwide over possible salmonella risk linked to a seasoning ingredient.
Subway closed 729 U.S. locations in 2025 as McDonald's gains ground, intensifying competition in the fast-food market.
The FDA has approved fruit-flavored e-cigarettes for adult smokers, sparking debate over youth vaping risks and public health concerns.
A Spirit Airlines pilot delivered an emotional farewell to passengers after the sudden shutdown of the airline following failed bailout efforts
Purdue Pharma has been sentenced to pay $5.5 billion after pleading guilty to deceiving regulators and fueling the US opioid crisis through aggressive and illegal opioid sales practices.
Brazil's labor prosecutors have sued JBS over claims it bought cattle linked to forced labor, raising major concerns about supply chain oversight in the country's beef industry.
Ford Motor Company expects a $1.3 billion tariff refund after a Supreme Court ruling, boosting profits despite ongoing trade cost pressures.
Elon Musk accused Sam Altman of a "bait and switch" over OpenAI's direction during a heated court trial in California, escalating tensions in the high-stakes legal battle.
Spirit Airlines faces possible collapse as $500 million bailout talks stall, with creditors blocking a key government rescue plan.
American Airlines limits power banks to two per passenger and requires visibility on flights to reduce lithium battery fire risks.
Citadel CEO Ken Griffin criticizes NYC Mayor Zohran Mamdani's viral tax video as a personal attack, raising concerns over business climate.
Disney pauses ESPN spinoff plans as CEO Josh D'Amaro focuses on streaming growth and keeping the sports network in-house.
SpaceX has approved a bold pay package for Elon Musk tied to reaching a $7.5 trillion valuation and building a permanent human colony on Mars.
Thousands of U.S. businesses have had tariff refund claims rejected as a new federal system rolls out under strict rules.
Panera Bread faces backlash over its Salad Stuffers as employees raise concerns about food waste and product value.
Costco recalls heated socks after reports of burns, urging customers to stop use and return the product for a full refund.
French Broad Chocolates recalls bonbon products due to undeclared walnuts, warning of serious allergy risks and urging customers to return affected items.
United Airlines confirms it approached American Airlines for a merger, but talks failed after the proposal was rejected, raising competition concerns.
Paramount seeks FCC approval for foreign investment as its Warner Bros. Discovery acquisition moves forward.
Johnson & Johnson will sell diabetes and blood thinner drugs on TrumpRx as part of a U.S. push to reduce prescription medication costs.
Coast Guard suspends search after a crew member fell overboard from the Norwegian Breakaway during a Bermuda to Boston voyage.
An American YouTuber is showing foreign visitors China's advanced electric vehicles at the Beijing Auto Show, highlighting technology and prices not yet available to U.S. buyers.
Walmart recalls 50,000 adjustable dumbbells after reports of injuries caused by weight plates detaching during use, prompting urgent safety warnings.
Donald Trump's new psychedelics order aims to speed research but raises concerns about slow federal drug policy progress and delays.
Tesla has reached a settlement in a Florida wrongful death case tied to a 2018 crash involving a disputed speed limiter feature and teenage fatalities.
Elon Musk has been summoned in Paris for a voluntary interview as French investigators probe allegations involving X, including deepfakes, illegal content, and possible platform misuse.
Rivian Automotive faces a setback after a tornado damages its Illinois factory, impacting R2 production operations but leaving workers safe.
Apple names John Ternus as CEO as Tim Cook shifts to chairman, marking a major leadership transition amid growing AI and global challenges.
Eli Lilly is reportedly nearing a $2 billion deal to acquire Kelonia Therapeutics, aiming to expand its cancer treatment portfolio with next-generation therapies.


































